Preprint · OA
via OpenAlex
Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions
Kaitlin A. Freeberg, CeAnn C. Udovich, Christopher R. Martens, Douglas R. Seals, Daniel Harrison Craighead
The Journals of Gerontology Series A · 2023 · ▲ 61 citations
Abstract
Advancing age and many disease states are associated with declines in nicotinamide adenine dinucleotide (NAD+) levels. Preclinical studies suggest that boosting NAD+ abundance with precursor compounds, such as nicotinamide riboside or nicotinamide mononucleotide, has profound effects on physiological function in models of aging and disease. Translation of these compounds for oral supplementation in humans has been increasingly studied within the last 10 years; however, the clinical evidence that raising NAD+ concentrations can improve physiological function is unclear. The goal of this review was to synthesize the published literature on the effects of chronic oral supplementation with NAD+ precursors on healthy aging and age-related chronic diseases. We identified nicotinamide riboside, nicotinamide riboside co-administered with pterostilbene, and nicotinamide mononucleotide as the most common candidates in investigations of NAD+-boosting compounds for improving physiological function in humans. Studies have been performed in generally healthy midlife and older adults, adults with cardiometabolic disease risk factors such as overweight and obesity, and numerous patient populations. Supplementation with these compounds is safe, tolerable, and can increase the abundance of NAD+ and related metabolites in multiple tissues. Dosing regimens and study durations vary greatly across interventions, and small sample sizes limit data interpretation of physiological outcomes. Limitations are identified and future research directions are suggested to further our understanding of the potential efficacy of NAD+-boosting compounds for improving physiological function and extending human health span.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/gerona/glad106
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Freeberg, K.A., Udovich, C.C., Martens, C.R., Seals, D.R., & Craighead, D.H. (2023). Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions. <em>The Journals of Gerontology Series A</em>. https://doi.org/10.1093/gerona/glad106
Vancouver
Freeberg KA, Udovich CC, Martens CR, Seals DR, Craighead DH. Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions. The Journals of Gerontology Series A. 2023. doi:10.1093/gerona/glad106.
BibTeX
@unpublished{kaitlin2023Dietar,
title = {Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions},
author = {Kaitlin A. Freeberg and CeAnn C. Udovich and Christopher R. Martens and Douglas R. Seals and Daniel Harrison Craighead},
journal = {The Journals of Gerontology Series A},
year = {2023},
doi = {10.1093/gerona/glad106},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Communications 2018
Open access · CC-BY
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
University of Colorado, Boulder 2015
Open access · US-GOV
Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults
Science Advances 2023
Open access · CC-BY
What is really known about the effects of nicotinamide riboside supplementation in humans
Frontiers in Cardiovascular Medicine 2022
Open access · CC-BY
Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Midlife and Older Adults
Aging Cell 2022
Open access · CC-BY
Oral nicotinamide riboside raises NAD + and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
Current nutrition reports 2026
Open access · OA